Variant report

Variant	nsv525526
Chromosome Location	chr16:65257891-65308021
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr16:65261934-65263743	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr16:65259923-65260594	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr16:65260879-65261827	H1-hESC	embryonic stem cell:	n/a	n/a
4	BRCA1	chr16:65259709-65259713	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr16:65263125-65263403	HepG2	liver:	n/a	chr16:65263228-65263239
6	CEBPB	chr16:65277192-65277826	HepG2	liver:	n/a	chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277714-65277725 chr16:65277716-65277725 chr16:65277716-65277725 chr16:65277714-65277727 chr16:65277368-65277379 chr16:65277716-65277725 chr16:65277688-65277701
7	CEBPB	chr16:65277562-65277865	K562	blood:	n/a	chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277714-65277725 chr16:65277716-65277725 chr16:65277716-65277725 chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277688-65277701
8	CEBPB	chr16:65277559-65277787	A549	lung:	n/a	chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277714-65277725 chr16:65277716-65277725 chr16:65277716-65277725 chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277688-65277701
9	CEBPB	chr16:65277539-65277817	IMR90	lung:	n/a	chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277714-65277725 chr16:65277716-65277725 chr16:65277716-65277725 chr16:65277714-65277727 chr16:65277716-65277725 chr16:65277688-65277701
10	CEBPB	chr16:65263041-65263616	IMR90	lung:	n/a	chr16:65263228-65263239
11	CHD1	chr16:65267320-65267871	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD1	chr16:65262256-65263399	H1-hESC	embryonic stem cell:	n/a	n/a
13	CHD1	chr16:65268167-65268806	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD1	chr16:65260916-65260999	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr16:65262223-65263612	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr16:65258541-65259225	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr16:65260886-65261812	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr16:65283840-65283990	HCPEpiC	choroid plexus:	n/a	n/a
19	CTCF	chr16:65269012-65269065	GM10266	blood:	n/a	n/a
20	CTCF	chr16:65283920-65284070	AG09319	gingival:	n/a	chr16:65283975-65283993
21	CTCF	chr16:65307900-65308050	HEEpiC	esophagus:	n/a	n/a
22	CTCF	chr16:65267573-65267649	GM20000	blood:	n/a	n/a
23	CTCF	chr16:65283920-65284070	HCPEpiC	choroid plexus:	n/a	chr16:65283975-65283993
24	CTCF	chr16:65283900-65284050	HCM	heart:	n/a	chr16:65283975-65283993
25	CTCF	chr16:65283923-65284047	NHEK	skin:	n/a	chr16:65283975-65283993
26	CTCF	chr16:65283880-65284030	HPAF	blood vessel:	n/a	chr16:65283975-65283993
27	EP300	chr16:65278755-65278983	SK-N-SH_RA	brain:	n/a	n/a
28	EP300	chr16:65278756-65279095	SK-N-SH_RA	brain:	n/a	n/a
29	EP300	chr16:65305803-65306322	SK-N-SH_RA	brain:	n/a	chr16:65305995-65306009
30	EP300	chr16:65305835-65306284	SK-N-SH_RA	brain:	n/a	chr16:65305995-65306009
31	EP300	chr16:65269701-65270128	H1-hESC	embryonic stem cell:	n/a	n/a
32	FOXA2	chr16:65264461-65264931	A549	lung:	n/a	n/a
33	GATA3	chr16:65302060-65302329	SH-SY5Y	brain:	n/a	n/a
34	GTF2F1	chr16:65263017-65263208	H1-hESC	embryonic stem cell:	n/a	n/a
35	GTF2F1	chr16:65261270-65261456	H1-hESC	embryonic stem cell:	n/a	n/a
36	GTF2F1	chr16:65269847-65270039	H1-hESC	embryonic stem cell:	n/a	n/a
37	GTF2F1	chr16:65262210-65262590	H1-hESC	embryonic stem cell:	n/a	n/a
38	JUN	chr16:65276424-65276750	HepG2	liver:	n/a	chr16:65276578-65276591
39	JUND	chr16:65262109-65262396	HepG2	liver:	n/a	chr16:65262200-65262208 chr16:65262313-65262322
40	JUND	chr16:65259651-65259712	H1-hESC	embryonic stem cell:	n/a	n/a
41	JUND	chr16:65276427-65276750	HepG2	liver:	n/a	n/a
42	JUND	chr16:65263428-65263601	H1-hESC	embryonic stem cell:	n/a	n/a
43	JUND	chr16:65261143-65261487	H1-hESC	embryonic stem cell:	n/a	n/a
44	JUND	chr16:65261171-65261355	H1-hESC	embryonic stem cell:	n/a	n/a
45	JUND	chr16:65259121-65259223	H1-hESC	embryonic stem cell:	n/a	n/a
46	JUND	chr16:65262885-65263528	H1-hESC	embryonic stem cell:	n/a	n/a
47	MAFK	chr16:65263034-65263235	IMR90	lung:	n/a	n/a
48	MAFK	chr16:65274323-65274488	HepG2	liver:	n/a	n/a
49	MAX	chr16:65259552-65259752	H1-hESC	embryonic stem cell:	n/a	n/a
50	MAX	chr16:65302205-65302382	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:65269452-65269502	HIPEpiC	eye:	n/a
2	chr16:65262350-65262400	GM12878	blood:	n/a
3	chr16:65269452-65269502	H1-hESC	embryonic stem cell:	embryo
4	chr16:65262350-65262400	AG10803	skin:	n/a
5	chr16:65262350-65262400	HPAEpiC	pulmonary alveolar:	n/a
6	chr16:65261243-65261293	HRCEpiC	kidney:	n/a
7	chr16:65269452-65269502	K562	blood:	n/a
8	chr16:65261243-65261293	AG09319	gingival:	n/a
9	chr16:65262350-65262400	K562	blood:	n/a
10	chr16:65269452-65269502	PANC-1	pancreas:	n/a
11	chr16:65269452-65269502	HMEC	breast:	n/a
12	chr16:65261243-65261293	SKMC	muscle:	n/a
13	chr16:65261243-65261293	AoSMC	blood vessel:	n/a
14	chr16:65261243-65261293	ECC-1	luminal epithelium:	n/a
15	chr16:65261243-65261293	HPAEpiC	pulmonary alveolar:	n/a
16	chr16:65262350-65262400	HAEpiC	amniotic membrane:	n/a
17	chr16:65262350-65262400	BE2_C	brain:	n/a
18	chr16:65262350-65262400	GM12892	blood:	n/a
19	chr16:65262350-65262400	HRE	kidney:	n/a
20	chr16:65269452-65269502	U87	brain:	n/a
21	chr16:65269452-65269502	HNPCEpiC	eye:	n/a
22	chr16:65269452-65269502	GM06990	blood:	n/a
23	chr16:65261243-65261293	GM06990	blood:	n/a
24	chr16:65261243-65261293	Jurkat	blood:	n/a
25	chr16:65261243-65261293	HCPEpiC	choroid plexus:	n/a
26	chr16:65261243-65261293	HIPEpiC	eye:	n/a
27	chr16:65262350-65262400	SK-N-MC	brain:	n/a
28	chr16:65261243-65261293	SK-N-MC	brain:	n/a
29	chr16:65262350-65262400	NT2-D1	testis:	n/a
30	chr16:65269452-65269502	HRPEpiC	eye:	n/a
31	chr16:65269452-65269502	AG09319	gingival:	n/a
32	chr16:65269452-65269502	ECC-1	luminal epithelium:	n/a
33	chr16:65262350-65262400	HEEpiC	esophagus:	n/a
34	chr16:65269452-65269502	HRCEpiC	kidney:	n/a
35	chr16:65261243-65261293	NH-A	brain:	n/a
36	chr16:65262350-65262400	Caco-2	colon:	n/a
37	chr16:65261243-65261293	H1-hESC	embryonic stem cell:	embryo
38	chr16:65269452-65269502	NHDF-neo	bronchial:	n/a
39	chr16:65269452-65269502	HepG2	liver:	n/a
40	chr16:65262350-65262400	HRPEpiC	eye:	n/a
41	chr16:65269452-65269502	AG04449	skin:	fetal
42	chr16:65269452-65269502	GM12891	blood:	n/a
43	chr16:65262350-65262400	RPTEC	kidney:	n/a
44	chr16:65269452-65269502	NHBE	bronchial:	n/a
45	chr16:65269452-65269502	SK-N-SH_RA	brain:	n/a
46	chr16:65269452-65269502	HCT-116	colon:	n/a
47	chr16:65261243-65261293	HMEC	breast:	n/a
48	chr16:65262350-65262400	GM19239	blood:	n/a
49	chr16:65261243-65261293	NB4	blood:	n/a
50	chr16:65262350-65262400	ProgFib	skin:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr16:65284590..65286307-chr16:65286570..65288207,2	MCF-7	breast:
2	chr16:65284590..65286307-chr16:65286570..65288207,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CDH11-2	chr16:65264160-65264260	NONHSAT142974
2	lnc-CDH5-3	chr16:65285627-65285772	ENSG00000260364.1
3	lnc-CDH11-2	chr16:65263884-65264121	NONHSAT142974
4	lnc-CDH11-2	chr16:65261798-65261924	ENSG00000260834.1
5	lnc-CDH11-2	chr16:65264636-65264782	NONHSAT142974
6	lnc-CDH11-2	chr16:65268789-65268807	ENSG00000260834.1
7	lnc-CDH11-2	chr16:65266918-65267013	NONHSAT142974
8	lnc-CDH11-2	chr16:65268789-65268867	NONHSAT142974
9	lnc-CDH11-2	chr16:65261690-65261924	NONHSAT142974
10	lnc-CDH5-3	chr16:65266959-65267083	ENSG00000260364.1

Variant related genes	Relation type
ENSG00000260364	TF binding region
ENSG00000260834	TF binding region
ENSG00000260364	CpG island
ENSG00000260834	CpG island

Extended variants
information (count: 1593 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:1593 , 50 per page) page: 1 2 3 4 5 6 7 ... 32

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7189335	chr16:65257891-65257892	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs72796916	chr16:65257905-65257906	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs574885258	chr16:65257908-65257909	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs555075911	chr16:65257977-65257978	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs543504616	chr16:65258080-65258081	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs567584110	chr16:65258082-65258083	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs542433777	chr16:65258164-65258165	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs535005499	chr16:65258187-65258188	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs553234203	chr16:65258210-65258211	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs562735030	chr16:65258220-65258221	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs185191175	chr16:65258243-65258244	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs16968729	chr16:65258244-65258245	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs538453336	chr16:65258392-65258393	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs73590073	chr16:65258416-65258417	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs146405204	chr16:65258465-65258466	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs548806000	chr16:65258469-65258470	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs148549114	chr16:65258523-65258524	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs551823800	chr16:65258534-65258535	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs116152976	chr16:65258551-65258552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs150633969	chr16:65258569-65258570	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs139794182	chr16:65258571-65258572	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs539467072	chr16:65258587-65258588	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs546613615	chr16:65258615-65258616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs571771862	chr16:65258631-65258632	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs188337442	chr16:65258670-65258671	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs556702565	chr16:65258685-65258686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs566812008	chr16:65258700-65258701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs112802737	chr16:65258704-65258705	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs535705868	chr16:65258713-65258714	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs9923878	chr16:65258722-65258723	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs575318267	chr16:65258803-65258804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs181202548	chr16:65258845-65258846	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs34276707	chr16:65258849-65258850	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs557210470	chr16:65258876-65258877	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs532778764	chr16:65258977-65258978	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs112126006	chr16:65259062-65259063	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs9934772	chr16:65259073-65259074	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs545842368	chr16:65259079-65259080	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs559314061	chr16:65259096-65259097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs185810421	chr16:65259129-65259130	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs373131371	chr16:65259236-65259237	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs191821834	chr16:65259251-65259252	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs183597766	chr16:65259262-65259263	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs369374623	chr16:65259264-65259265	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs561218999	chr16:65259274-65259275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs536988862	chr16:65259300-65259301	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs562319869	chr16:65259303-65259304	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs547767741	chr16:65259312-65259313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs7195314	chr16:65259345-65259346	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs551130360	chr16:65259397-65259398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Bladder cancer	21909424	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21806811	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	22286061	CNVD
Autism	18414403	CNVD
Breast cancer	20409316	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Ovarian cancer	21720365	CNVD
Leiomyosarcoma	16982739	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	22241247	CNVD
Mental retardation	21062444	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Infiltrating lobular breast cancer	19191266	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Urothelial carcinoma	21177765	CNVD

Chromatin state (count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:65254200-65263000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr16:65256600-65258400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
3	chr16:65256600-65259400	Enhancers	HUES6 Cell Line	embryonic stem cell
4	chr16:65256800-65258000	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr16:65257200-65258000	Enhancers	ES-I3 Cell Line	embryonic stem cell
6	chr16:65257400-65258000	Enhancers	iPS-20b Cell Line	embryonic stem cell
7	chr16:65257400-65259000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr16:65257600-65258000	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr16:65257600-65258600	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr16:65257600-65258600	Weak transcription	HUES48 Cell Line	embryonic stem cell
11	chr16:65257600-65265200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr16:65258000-65258400	Weak transcription	HUES64 Cell Line	embryonic stem cell
13	chr16:65258000-65258400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
14	chr16:65258000-65258400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
15	chr16:65258000-65261800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
16	chr16:65258200-65258600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr16:65258400-65259600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr16:65258400-65259800	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr16:65258400-65260800	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr16:65258400-65260800	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr16:65258400-65261200	Enhancers	iPS-15b Cell Line	embryonic stem cell
22	chr16:65258600-65259600	Enhancers	H9 Cell Line	embryonic stem cell
23	chr16:65258600-65260200	Enhancers	H1 Cell Line	embryonic stem cell
24	chr16:65258600-65261000	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr16:65258600-65261400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr16:65259000-65259600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr16:65259200-65259400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
28	chr16:65259400-65260200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
29	chr16:65259400-65260200	Weak transcription	HUES6 Cell Line	embryonic stem cell
30	chr16:65259600-65261000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr16:65259600-65261200	Weak transcription	H9 Cell Line	embryonic stem cell
32	chr16:65259600-65261200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr16:65259800-65261000	Weak transcription	HUES64 Cell Line	embryonic stem cell
34	chr16:65260200-65260400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr16:65260200-65261200	Weak transcription	H1 Cell Line	embryonic stem cell
36	chr16:65260200-65261200	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr16:65260400-65260800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
38	chr16:65260800-65261600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
39	chr16:65260800-65262200	Genic enhancers	iPS-20b Cell Line	embryonic stem cell
40	chr16:65260800-65262800	Genic enhancers	iPS-18 Cell Line	embryonic stem cell
41	chr16:65261000-65261400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr16:65261000-65261400	Genic enhancers	HUES48 Cell Line	embryonic stem cell
43	chr16:65261000-65263000	Strong transcription	HUES64 Cell Line	embryonic stem cell
44	chr16:65261200-65261600	Genic enhancers	H1 Cell Line	embryonic stem cell
45	chr16:65261200-65262000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
46	chr16:65261200-65262600	Genic enhancers	HUES6 Cell Line	embryonic stem cell
47	chr16:65261200-65263000	Strong transcription	H9 Cell Line	embryonic stem cell
48	chr16:65261200-65263000	Strong transcription	iPS DF 6.9 Cell Line	embryonic stem cell
49	chr16:65261400-65262400	Strong transcription	HUES48 Cell Line	embryonic stem cell
50	chr16:65261400-65262600	Strong transcription	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links